Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters, Brachytherapy)), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
- Report ID: GVR-1-68038-086-6
- Number of Pages: 170
- Format: Electronic (PDF)
- Historical Range: 2018 - 2021
- Industry: Healthcare
Market Segmentation
- Global Nuclear Medicine Market: Product Outlook (Revenue, USD Million, 2018 - 2030)
- Diagnostic Products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic Products
- Global Nuclear Medicine Market: Application Type Outlook (Revenue, USD Million, 2018 - 2030)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Global Nuclear Medicine Market: End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Global Nuclear Medicine: Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- U.S. Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- U.S. Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- U.S. Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- U.S. Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Canada
- Canada Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Canada Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Canada Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Canada Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- U.S.
- Europe
- UK
- UK Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- UK Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- UK Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Germany
- Germany Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Germany Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Germany Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Germany Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- France
- France Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- France Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- France Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- France Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Italy
- Italy Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Italy Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Italy Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Italy Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Spain
- Spain Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Spain Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Spain Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Spain Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Russia
- Russia Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Russia Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Russia Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Russia Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Netherlands
- Netherlands Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Netherlands Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Netherlands Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Netherlands Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Denmark
- Denmark Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Denmark Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Denmark Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Denmark Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Sweden
- Sweden Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Sweden Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Sweden Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Sweden Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Norway
- Norway Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Norway Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Norway Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Norway Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Asia Pacific
- Japan
- Japan Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Japan Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Japan Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- China
- China Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- China Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- China Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- India
- India Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- India Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- India Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Australia
- Australia Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Australia Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Australia Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- South Korea
- South Korea Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- South Korea Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- South Korea Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Singapore
- Singapore Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Singapore Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Singapore Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Thailand
- Thailand Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Thailand Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Thailand Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Philippines
- Philippines Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Philippines Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Philippines Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- New Zealand
- New Zealand Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- New Zealand Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- New Zealand Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Malaysia
- Malaysia Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Malaysia Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Malaysia Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Latin America
- Brazil
- Brazil Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Brazil Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Brazil Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Brazil Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Mexico
- Mexico Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Mexico Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Mexico Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Mexico Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Argentina
- Argentina Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Argentina Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Argentina Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Argentina Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Brazil
- MEA
- South Africa
- South Africa Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- South Africa Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- South Africa Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- South Africa Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Saudi Arabia
- Saudi Arabia Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Saudi Arabia Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Saudi Arabia Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Saudi Arabia Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- UAE
- UAE Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- UAE Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- UAE Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- UAE Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Turkey
- Turkey Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Turkey Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Turkey Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Turkey Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Israel
- Israel Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Israel Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Israel Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Israel Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Kuwait
- Kuwait Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- Diagnostic products
- SPECT
- TC-99m
- TL-201
- GA-67
- I-123
- Other SPECT products
- PET
- F-18
- SR-82/RB-82
- Other PET products
- SPECT
- Therapeutic Products
- Alpha Emitters
- RA-223
- Others
- Beta Emitters
- I-131
- Y-90
- SM-153
- Re-186
- Lu-117
- Other beta emitters
- Brachytherapy
- Cesium-131
- Iodine-125
- Palladium-103
- Iridium-192
- Other brachytherapy products
- Alpha Emitters
- Diagnostic products
- Kuwait Nuclear Medicine Market, By Application, 2018 - 2030 (USD Million)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- Kuwait Nuclear Medicine Market, By End-use, 2018 - 2030 (USD Million)
- Hospitals & Clinics
- Diagnostic Centers
- Others
- Kuwait Nuclear Medicine Market, By Product 2018 - 2030 (USD Million)
- South Africa
- North America
Nuclear Medicine Market Dynamics
Driver - Rising Incidence of Cancer and Cardiovascular Diseases
Increasing demand for early and accurate diagnosis of diseases, coupled with growing demand for enhanced therapies, is expected to fuel the market. According to WHO, globally, cancer is the second leading cause of death. In 2020, the number of new cases reached 19.3 million and projected deaths due to cancer were at 9.96 million. According to the International Agency for Research on Cancer, the number of new cases is expected to reach 21.9 million by 2025. The top three cancers are lung (2.51 million cases), breast (2.46 million cases), and prostate (1.61 million cases). The number of new cases of cancer is expected to reach 24.6 million by 2030. This figure exhibits significant growth in the number of cancer cases worldwide. Moreover, the high prevalence of cancer in emerging Asian economies is creating a major demand for radiopharmaceuticals. According to GLOBOCAN, in 2020, approximately 49.2% of global cancer cases were registered in Asia. Thus, this region remains a vast untapped market for radiopharmaceuticals.
Driver - Increasing Application of Radiopharmaceuticals/Nuclear Medicine
Currently, radiopharmaceuticals are widely used in the fields of cardiology and oncology. Ongoing research & studies demonstrating positive results are expanding the application of radioisotopes in the diagnosis & treatment of cancer, thyroid-related diseases, respiratory diseases, bone diseases, and digestive tract conditions. For instance, in December 2019, a research team from Helmholtz-Zentrum Dresden-Rossendorf (HZDR) published a study on [18F] FACH, to diagnose tumor-relevant transport proteins. They developed 18F-radiolabeled MCT1/MCT4 inhibitor FACH (Monocarboxylate transporters 1 and 4) from a one-step synthesis to visualize special transport proteins found in the membranes of cancer cells. It was found that the new procedure gives high radiochemical yields of 43 ± 8% with reduced synthesis time. Furthermore, the radiosynthesis was transferred to the TRACERlab FX2 N system for future preclinical applications of [18F] FACH. Technetium-99m is one of the most commonly used radioisotopes in radiopharmaceuticals. Other widely used radioisotopes include Iodine-131, Indium-111, and Fluorine-18. These medical isotopes are also commonly used in radiopharmacology to study drug movement in lab subjects.
Restraint - Stringent Regulations Pertaining to Production, Storage, and Usage
Radioactive substances are capable of mutating genes and may cause severe adverse effects, including fatalities. Thus, handling radioactive substances is strictly regulated by governments to ensure compliance with radiation safety policies. Approval procedures for products containing radioactive substances are stringent, which delays their launch in the market. In addition, regulations mandate the hiring of skilled professionals for the installation and operation of instruments involving radioactive materials. Thus, stringent government regulations are likely to limit market growth during the forecast period. Moreover, the U.S. has made efforts to minimize the export of Highly Enriched Uranium (HEU) used for the production of medical radioisotopes as part of its nuclear non-proliferation objectives and subsequently increased efforts for the production of medical isotopes using low-enriched uranium, resulting in higher costs of production.
What Does This Report Include?
This section will provide insights into the contents included in this nuclear medicine market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Nuclear medicine market qualitative analysis
-
Industry overview
-
Industry trends
-
Market drivers and restraints
-
Market size
-
Growth prospects
-
Porter’s analysis
-
PESTEL analysis
-
Key market opportunities prioritized
-
Competitive landscape
-
Company overview
-
Financial performance
-
Product benchmarking
-
Latest strategic developments
-
Nuclear medicine market quantitative analysis
-
Market size, estimates, and forecast from 2018 to 2030
-
Market estimates and forecast for product segments up to 2030
-
Regional market size and forecast for product segments up to 2030
-
Market estimates and forecast for application segments up to 2030
-
Regional market size and forecast for application segments up to 2030
-
Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
